Table 1.
Demographics and clinical data.
| Complete sample (n = 30) | Subsample* (n = 18) | |||
|---|---|---|---|---|
| Mean [±SD] | Median (range) | Mean [±SD] | Median (range) | |
| Age | 61.67 [±9.46] | 62 (40–75) | 60.11 [±9.04] | 61 (44–75) |
| MoCA | 26.67 [±3] | 27 (15–30) | 26.72 [±3.5] | 27 (15–30) |
| ExecDom | −0.254 [±0.73] | −0.125 (−1.37–1.26) | −0.297 [±0.67] | −0.125 (−1.35–0.99) |
| MemDom | −0.51 [±1.2] | −0.41 (−2.81–1.47) | −0.73 [±1.26] | −0.51 (−2.81–1.25) |
| VspDom | 0.06 [±0.78] | −0.06 (−1.57–0.95) | 0.08 [±0.84] | 0.44 (−1.57–0.95) |
| UPDRS III | 20.2 [±10.6] | 17 (7–47) | 19.83 [±10.9] | 17 (7–47) |
Male/Female ratio was 2:1.
*
Subsample of subjects who had both fMRI and DaTSCAN acquired within less than a week interval.
MoCA, the Montreal Cognitive Assessment; ExecDom, “Executive” domain; MemDom, “Memory” domain; VspDom, “Visuospatial” domain; UPDRS III, part III of the Unified Parkinson's Disease Rating Scale.